China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE: 300294)

China Resources Boya Bio-pharmaceutical Group Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,252	1,961	1,532	1,584	753.89	568.75
Trading Asset Securities	2,242	3,362	3,194	2,700	-	-
Cash & Short-Term Investments	5,494	5,324	4,726	4,284	753.89	568.75
Cash Growth	10.13%	12.66%	10.31%	468.21%	32.55%	-52.34%
Accounts Receivable	380.7	275.92	567.02	588.08	681.01	970.14
Other Receivables	191.11	264.4	100.62	67.9	53.21	39.31
Receivables	571.81	540.32	667.64	655.98	734.22	1,009
Inventory	577.32	556.94	666.96	676.84	689.46	621.4
Other Current Assets	3.3	6.43	13.25	29.4	750.08	853.38
Total Current Assets	6,647	6,428	6,073	5,646	2,928	3,053
Property, Plant & Equipment	668.69	676.62	722.81	771.33	809.52	814.8
Long-Term Investments	194.3	100.39	117.09	144.96	311.66	133.34
Goodwill	72.61	72.61	663.84	663.84	663.84	663.84
Other Intangible Assets	267.21	269.31	312.17	169.47	198.6	175.61
Long-Term Deferred Tax Assets	50.09	47.34	44.99	27.44	20.57	26
Long-Term Deferred Charges	92.51	88.15	82.64	161.62	166.41	161.01
Other Long-Term Assets	31.14	146.83	16.24	37.2	60.27	229.1
Total Assets	8,023	7,829	8,033	7,622	5,159	5,257
Accounts Payable	138.49	126.35	303.46	277.53	285.88	250.67
Accrued Expenses	280.41	274.14	290.9	261.19	83.94	273.58
Short-Term Debt	-	-	-	-	220.2	256.83
Current Portion of Long-Term Debt	22.17	0.03	22.18	0.08	55.2	97.56
Current Portion of Leases	0.79	0.87	2.81	2.06	-	-
Current Income Taxes Payable	29.17	8.58	27.09	41.45	20.54	30.1
Current Unearned Revenue	5.79	12.21	20.58	12.97	14.51	-
Other Current Liabilities	31.43	34.26	38.33	35.66	191.66	47.77
Total Current Liabilities	508.25	456.45	705.34	630.94	871.93	956.51
Long-Term Debt	-	22.15	-	22.15	55	269
Long-Term Leases	3.9	1.4	10.37	11.3	-	-
Long-Term Unearned Revenue	21.51	23.52	27.09	30.98	32.44	35.77
Long-Term Deferred Tax Liabilities	4.42	4.56	5.56	5.94	6.71	6.83
Total Liabilities	538.09	508.07	748.35	701.3	966.08	1,268
Common Stock	504.25	504.25	504.25	511.63	433.32	433.32
Additional Paid-In Capital	4,063	4,063	4,065	4,258	1,947	1,947
Retained Earnings	2,917	2,753	2,616	2,259	1,928	1,732
Treasury Stock	-	-	-	-199.96	-199.96	-199.96
Total Common Equity	7,484	7,320	7,186	6,829	4,108	3,912
Minority Interest	0.81	1.07	99.19	91.4	84.55	76.85
Shareholders' Equity	7,485	7,321	7,285	6,920	4,192	3,989
Total Liabilities & Equity	8,023	7,829	8,033	7,622	5,159	5,257
Total Debt	26.86	24.45	35.36	35.58	330.39	623.39
Net Cash (Debt)	5,468	5,299	4,690	4,248	423.5	-54.64
Net Cash Growth	10.33%	12.99%	10.41%	903.09%	-	-
Net Cash Per Share	10.82	10.49	9.33	9.74	0.99	-0.13
Filing Date Shares Outstanding	504.25	504.25	504.25	504.25	425.94	425.94
Total Common Shares Outstanding	504.25	504.25	504.25	504.25	425.94	425.94
Working Capital	6,139	5,971	5,368	5,015	2,056	2,096
Book Value Per Share	14.84	14.52	14.25	13.54	9.64	9.18
Tangible Book Value	7,145	6,978	6,210	5,996	3,245	3,072
Tangible Book Value Per Share	14.17	13.84	12.31	11.89	7.62	7.21
Buildings	524.97	527.95	518.01	536.62	506.23	465.93
Machinery	637.81	625.83	671.97	665.73	632.37	627.88
Construction In Progress	55.27	39.94	69.34	40.86	80.9	94.55

Source: S&P Capital IQ. Standard template. Financial Sources.